Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives

Lung cancer is the leading cause of cancer deaths in the world. Surgery is the most potentially curative therapeutic option for patients with early-stage non-small cell lung cancer (NSCLC). The five-year survival for these patients remains poor and variable, depending on the stage of disease at diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzari, Chiara, Spagnolo, Calogera Claudia, Ciappina, Giuliana, Di Pietro, Martina, Squeri, Andrea, Passalacqua, Maria Ilenia, Marchesi, Silvia, Gregorc, Vanesa, Santarpia, Mariacarmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136903/
https://www.ncbi.nlm.nih.gov/pubmed/37185393
http://dx.doi.org/10.3390/curroncol30040280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136903/
https://www.ncbi.nlm.nih.gov/pubmed/37185393
http://dx.doi.org/10.3390/curroncol30040280

Ejemplares similares